Satellos Bioscience Inc. (MSCL : TSX)
Common Stock
$9.02
CAD
-0.29 (-3.11%)
Last updated: 2026-11-05
Follow MSCL
MSCL
Satellos Bioscience Inc.
WealthAwesomePerformance
1 Day
+3.44%
1 Week
+3.10%
1 Month
-19.04%
YTD
+10.83%
Key Statistics
Market Cap
$191.37M
52W High
$18.98
52W Low
$7.56
P/E Ratio
-
50 Day MA
$11.44
200 Day MA
$11.72
Beta
1.19
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 11/5/2026 | $9.08 | $9.08 | $8.65 | $9.02 | $9.02 | 34,191 |
| 11/4/2026 | $9.00 | $9.31 | $9.00 | $9.31 | $9.31 | 401 |
| 11/3/2026 | $9.08 | $9.11 | $9.00 | $9.00 | $9.00 | 7,819 |
| 11/2/2026 | $9.32 | $9.32 | $9.05 | $9.05 | $9.05 | 826 |
| 10/30/2026 | $9.60 | $9.60 | $9.05 | $9.54 | $9.54 | 3,137 |
| 10/29/2026 | $9.08 | $9.76 | $9.05 | $9.60 | $9.60 | 3,019 |
| 10/28/2026 | $9.67 | $9.88 | $9.01 | $9.03 | $9.03 | 13,760 |
| 10/27/2026 | $9.52 | $10.00 | $9.52 | $9.67 | $9.67 | 9,036 |
| 10/26/2026 | $9.25 | $9.33 | $9.00 | $9.33 | $9.33 | 11,145 |
| 10/23/2026 | $9.23 | $9.38 | $9.05 | $9.13 | $9.13 | 7,208 |
Analyst Price Targets
Based on analyst covering MSCL · as of Sep 28, 2026
Wall Street analysts forecast MSCL stock price to rise 93.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$17.47
+93.7% Upside
Previously C$17.67 on Sep 17, 2026
Current Price
C$9.02
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MSCL's historical volatility
30-Day Vol
61.1%
Annualized
90-Day Vol
62.2%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$7.54
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$8.50 | C$6.88 – C$10.49 |
| 60 trading days | C$8.01 | C$5.94 – C$10.79 |
| 90 trading days | C$7.54 | C$5.24 – C$10.87 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Satellos Bioscience Inc.
Satellos Bioscience Inc., a clinical-stage drug development company, focuses on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia. The company uses its proprietary discovery platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. It develops SAT-3247, an oral, small molecule drug candidate for the treatment of Duchenne muscular dystrophy disease. The company has a license agreement the with Ottawa Hospital Research Institute (OHRI); and an option agreement with the University of British Columbia. Satellos Bioscience Inc. was founded in 2018 and is headquartered in Toronto, Canada.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-35.82M
- Profit Margin
- 0.00%
- ROE (TTM)
- -70.45%
- EPS (Diluted)
- -2.70
- Book Value
- 4.04
🔄 Recent Splits
1-for-12
Jan 30, 2026
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About MSCL
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| AAB | Aberdeen International Inc. | $0.02 | +33.33% |
| XMF-A | M Split Corp | $1.99 | +17.06% |
| CNT | Century Global Commodities Corp | $0.04 | +16.67% |
| LABS | Medipharm Labs Corp | $0.07 | +16.67% |
| HSTR | Heliostar Metals Ltd. | $2.24 | +15.46% |
| DSV | Discovery Silver Corp. | $11.09 | +15.28% |
| PRL | Propel Holdings Inc | $30.53 | +15.16% |
| HMM-A | Hammond Manufacturing Company Limited | $30.00 | +15.03% |
MSCL.TO news timeline
15 articles covering MSCL.TO, most recent first
Latest